John Orloff
InvestorVenture Partner at Agent Capital · Board director at Zenas Biopharma
About
Venture Partner who was previously EVP and Global Head of R&D at Alexion, and held R&D leadership roles at Baxalta, Baxter, Merck Serono and Novartis. He holds a medical degree from the University of Vermont.
Board director at Zenas Biopharma
Intro paths
→
In turn, John can intro founders to Zenas Biopharma's investors below.
Zenas Biopharma's investors · 8
Agent CapitalWaltham · since 2022Delos CapitalCambridgeLongitude CapitalMenlo Park · $10M – $30M checksNew Enterprise Associates (NEA)Menlo Park · $200K – $40M checksNorwest Venture PartnersMenlo Park · $10M – $30M checksQuan CapitalShanghaiSR One Capital ManagementRedwood City · since 2024Vivo CapitalPalo Alto · $10M – $50M checks
Co-founders at Zenas Biopharma
LO
LEON O. MOULDER, JR.Director
LM
Lonnie MoulderFounder, CEO & Chairman
Deals · 2
Zenas BiopharmaBoard seat
via Agent Capital · filed Nov 2022 · $183.9M raise
BenevolentAIBoard seat
via Agent Capital · filed Sep 2022
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Agent Capital
Alex Creasey
Partner & Co-Founder at Snowpoint
Andrea Heslin Smiley
Director at atai Life Sciences
Anthony DiNatale
Vice President at Agent Capital
Bob Hombach
Industry Advisor at Agent Capital
Bob Parkinson
Industry Advisor at Agent Capital
Bruce Peacock
Operating Partner at Agent Capital
Farah Champsi
Venture Advisor at Agent Capital
Geeta Vemuri
Managing Partner, Founder at Agent Capital
Frequently asked questions
- Who is John Orloff?
- Venture Partner who was previously EVP and Global Head of R&D at Alexion, and held R&D leadership roles at Baxalta, Baxter, Merck Serono and Novartis. He holds a medical degree from the University of Vermont.
- Where does John Orloff work?
- John Orloff is Venture Partner at Agent Capital and Board director at Zenas Biopharma.
- What boards does John Orloff sit on?
- John Orloff holds tracked board seats at BenevolentAI, Zenas Biopharma.